Ignite Creation Date:
2025-12-24 @ 10:59 PM
Ignite Modification Date:
2026-02-28 @ 6:33 PM
Study NCT ID:
NCT00886769
Status:
TERMINATED
Last Update Posted:
2017-03-29
First Post:
2009-04-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Systemic Juvenile Idiopathic Arthritis | View |